Lv5
1158 积分 2025-06-21 加入
Demonstration of a robust high cell density transient CHO platform yielding mAb titers of up to 2 g/L without medium exchange
1个月前
已完结
A high‐titer scalable Chinese hamster ovary transient expression platform for production of biotherapeutics
1个月前
已完结
Impact of cell culture on recombinant monoclonal antibody product heterogeneity
1个月前
已完结
Evaluation of heavy chain C‐terminal deletions on productivity and product quality of monoclonal antibodies in Chinese hamster ovary (CHO) cells
1个月前
已完结
Comparative study of therapeutic antibody candidates derived from mini‐pool and clonal cell lines
1个月前
已完结
Biopharmaceutical Industry Practices for Sequence Variant Analyses of Recombinant Protein Therapeutics
1个月前
已完结
Leveraging a CHO cell line toolkit to accelerate biotherapeutics into the clinic
1个月前
已完结
Demonstration of a robust high cell density transient CHO platform yielding mAb titers of up to 2 g/L without medium exchange
1个月前
已完结
Beyond preclinical research: production of CHO-derived biotherapeutics for toxicology and early-phase trials by transient gene expression or stable pools
1个月前
已完结
OAZ1/CASP8AP2 double knockout enhances recombinant protein production in HEK293 cells through metabolic reprogramming and antiapoptotic effects
2个月前
已完结
皖公网安备34019202002308
